Overview of the study cohort and main findings. The geographic distribution of collaborating centers (Spain, 17; Poland, 3; Italy, 2; France, 1; Serbia, 1; top left panel). The proportion of patients in each diagnostic group (top middle panel) and the most frequent concomitant diagnoses (bottom left panel). Overall survival of patients with an MPN-first diagnosis according to JAK2 mutation status (top right panel). Overall survival comparing patients with MPN-first versus LN-first diagnoses (bottom right panel).
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study
Borsani, O;Rumi, E;
2026-01-01
Abstract
Overview of the study cohort and main findings. The geographic distribution of collaborating centers (Spain, 17; Poland, 3; Italy, 2; France, 1; Serbia, 1; top left panel). The proportion of patients in each diagnostic group (top middle panel) and the most frequent concomitant diagnoses (bottom left panel). Overall survival of patients with an MPN-first diagnosis according to JAK2 mutation status (top right panel). Overall survival comparing patients with MPN-first versus LN-first diagnoses (bottom right panel).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
